Cardiac Biomarkers and Left Ventricular Hypertrophy in Relation to Outcomes in Patients With Atrial Fibrillation: Experiences From the RE‐LY Trial-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Cardiac Biomarkers and Left Ventricular Hypertrophy in Relation to Outcomes in Patients With Atrial Fibrillation: Experiences From the RE‐LY Trial

Published:2019-01-22 Issue:2 Volume:8 Page:
ISSN:2047-9980
Container-title:Journal of the American Heart Association
language:en
Short-container-title:J Am Heart Assoc

Author:

Hijazi Ziad¹²,Verdecchia Paolo³,Oldgren Jonas¹²,Andersson Ulrika²,Reboldi Gianpaolo⁴,Di Pasquale Giuseppe⁵,Mazzotta Giovanni³,Angeli Fabio⁶,Eikelboom John W.⁷,Ezekowitz Michael D.⁸,Connolly Stuart J.⁷,Yusuf Salim⁷,Wallentin Lars¹²

Affiliation:

1. Department of Medical Sciences Cardiology Uppsala University Uppsala Sweden

2. Uppsala Clinical Research Center Uppsala University Uppsala Sweden

3. Department of Medicine Hospital of Assisi Italy

4. Department of Medicine University of Perugia Italy

5. Department of Cardiology Maggiore Hospital Bologna Italy

6. Department of Cardiology and Cardiovascular Pathophysiology University of Perugia Perugia Italy

7. Population Health Research Institute Hamilton Ontario Canada

8. Thomas Jefferson Medical College and the Heart Center Wynnewood PA

Publisher

Ovid Technologies (Wolters Kluwer Health)

Subject

Cardiology and Cardiovascular Medicine

Reference41 articles.

1. Guidelines for the management of atrial fibrillation: The Task Force for the Management of Atrial Fibrillation of the European Society of Cardiology (ESC)

2. 2014 AHA/ACC/HRS Guideline for the Management of Patients With Atrial Fibrillation: Executive Summary

3. Prognostic Implications of Echocardiographically Determined Left Ventricular Mass in the Framingham Heart Study

4. Prognostic Usefulness of Left Ventricular Hypertrophy by Electrocardiography in Patients With Atrial Fibrillation (from the Randomized Evaluation of Long-Term Anticoagulant Therapy Study)

5. Cardiac Biomarkers Are Associated With an Increased Risk of Stroke and Death in Patients With Atrial Fibrillation

Cited by 17 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. 2024 ESC Guidelines for the management of elevated blood pressure and hypertension;European Heart Journal;2024-08-30

2. Interrelation of growth/differentiation factor-15 level with laboratory and clinical and functional parameters of patients with coronary artery disease;Cardiovascular Therapy and Prevention;2023-05-24

3. The Association of Leptin with Left Ventricular Hypertrophy in End-Stage Kidney Disease Patients on Dialysis;Biomedicines;2023-03-27

4. Left Ventricular Hypertrophy and Ventricular Tachyarrhythmia: The Role of Biomarkers;International Journal of Molecular Sciences;2023-02-15

5. Inflammageing and Cardiovascular System: Focus on Cardiokines and Cardiac-Specific Biomarkers;International Journal of Molecular Sciences;2023-01-03

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3